Cargando…

Raltegravir in the management of HIV-infected patients

Raltegravir has recently been licensed for the treatment of HIV-1 infection. Currently its use is limited to treatment-experienced patients and subjects with resistant virus. In addition to its activity in the setting of resistance and treatment failure, it appears to have great potential for first-...

Descripción completa

Detalles Bibliográficos
Autor principal: Stellbrink, Hans-Jürgen
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761196/
https://www.ncbi.nlm.nih.gov/pubmed/19920914